These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2114040)

  • 1. Economic aspects of cervical cancer screening.
    Koopmanschap MA; Lubbe KT; van Oortmarssen GJ; van Agt HM; van Ballegooijen M; Habbema JK
    Soc Sci Med; 1990; 30(10):1081-7. PubMed ID: 2114040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
    van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
    J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of home care for advanced breast and cervical cancer in relation to cost-effectiveness of screening.
    Koopmanschap MA; van Ineveld BM; Miltenburg TE
    Soc Sci Med; 1992 Oct; 35(8):979-85. PubMed ID: 1411705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Care and costs for advanced cervical cancer.
    van Ballegooijen M; Koopmanschap MA; Tjokrowardojo AJ; van Oortmarssen GJ
    Eur J Cancer; 1992; 28A(10):1703-8. PubMed ID: 1389489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs and effects of alternative screening programs against cervical cancer].
    Gyrd-Hansen D; Hølund B; Andersen P
    Ugeskr Laeger; 1996 Aug; 158(35):4912-5. PubMed ID: 8801698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical-cancer screening: attendance and cost-effectiveness.
    Koopmanschap MA; van Oortmarssen GJ; van Agt HM; van Ballegooijen M; Habbema JD; Lubbe KT
    Int J Cancer; 1990 Mar; 45(3):410-5. PubMed ID: 2106499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of cervical cancer screening for the elderly.
    Fahs MC; Mandelblatt J; Schechter C; Muller C
    Ann Intern Med; 1992 Sep; 117(6):520-7. PubMed ID: 1503355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
    Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
    Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.
    Nahvijou A; Daroudi R; Tahmasebi M; Amouzegar Hashemi F; Rezaei Hemami M; Akbari Sari A; Barati Marenani A; Zendehdel K
    PLoS One; 2016; 11(6):e0156705. PubMed ID: 27276093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
    Kim JJ; Leung GM; Woo PP; Goldie SJ
    J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R; Haas M; Shanahan M
    Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
    Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.
    Goldie SJ; Freedberg KA; Weinstein MC; Wright TC; Kuntz KM
    Am J Med; 2001 Aug; 111(2):140-9. PubMed ID: 11498068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.